Literature DB >> 25527563

Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites.

Emilie Mamessier1, Charlotte Drevet2, Florence Broussais-Guillaumot3, Marie-Laure Mollichella2, Sylvain Garciaz2, Sandrine Roulland2, Maxime Benchetrit4, Bertrand Nadel2, Luc Xerri5.   

Abstract

Entities:  

Keywords:  N-glycosylated sites; contiguous; follicular lymphoma in situ

Mesh：

Substances：

Year:  2014        PMID： 25527563      PMCID： PMC4380740          DOI： 10.3324/haematol.2014.115782

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event?

Authors:  K J McCann; P W M Johnson; F K Stevenson; C H Ottensmeier
Journal:  Leukemia       Date:  2006-03       Impact factor: 11.528

2.  Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression.

Authors:  R Küppers; K Rajewsky; M L Hansmann
Journal:  Eur J Immunol       Date:  1997-06       Impact factor: 5.532

3.  Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor.

Authors:  Catherine M Radcliffe; James N Arnold; David M Suter; Mark R Wormald; David J Harvey; Louise Royle; Yusuke Mimura; Yoshinobu Kimura; Robert B Sim; Susana Inogès; Mercedes Rodriguez-Calvillo; Natalia Zabalegui; Ascensión López-Díaz de Cerio; Kathleen N Potter; C Ian Mockridge; Raymond A Dwek; Maurizio Bendandi; Pauline M Rudd; Freda K Stevenson
Journal:  J Biol Chem       Date:  2006-12-29       Impact factor: 5.157

4.  Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma.

Authors:  Armin G Jegalian; Franziska C Eberle; Svetlana D Pack; Mariya Mirvis; Mark Raffeld; Stefania Pittaluga; Elaine S Jaffe
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

5.  Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma.

Authors:  J Schmidt; I Salaverria; A Haake; I Bonzheim; P Adam; S Montes-Moreno; M A Piris; F Fend; R Siebert; L Quintanilla-Martinez
Journal:  Leukemia       Date:  2013-10-23       Impact factor: 11.528

6.  Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins.

Authors:  Vania Coelho; Sergey Krysov; Amir M Ghaemmaghami; Mohamed Emara; Kathleen N Potter; Peter Johnson; Graham Packham; Luisa Martinez-Pomares; Freda K Stevenson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

7.  In situ localization of follicular lymphoma: description and analysis by laser capture microdissection.

Authors:  Peijie Cong; Mark Raffeld; Julie Teruya-Feldstein; Lynn Sorbara; Stefania Pittaluga; Elaine S Jaffe
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

8.  Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma.

Authors:  Katy J McCann; Christian H Ottensmeier; Alice Callard; Catherine M Radcliffe; David J Harvey; Raymond A Dwek; Pauline M Rudd; Brian J Sutton; Paul Hobby; Freda K Stevenson
Journal:  Mol Immunol       Date:  2007-11-19       Impact factor: 4.407

9.  Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages.

Authors:  P Allavena; M Chieppa; G Bianchi; G Solinas; M Fabbri; G Laskarin; A Mantovani
Journal:  Clin Dev Immunol       Date:  2011-02-09

10.  A unique case of follicular lymphoma provides insights to the clonal evolution from follicular lymphoma in situ to manifest follicular lymphoma.

Authors:  Irina Bonzheim; Itziar Salaverria; Andrea Haake; Günther Gastl; Patrick Adam; Reiner Siebert; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2011-09-22       Impact factor: 22.113
View more
  6 in total

1.  DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

Authors:  Rada Amin; Frédéric Mourcin; Fabrice Uhel; Céline Pangault; Philippe Ruminy; Loic Dupré; Marion Guirriec; Tony Marchand; Thierry Fest; Thierry Lamy; Karin Tarte
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

Review 2.  The heterogeneity of follicular lymphomas: from early development to transformation.

Authors:  Luc Xerri; Stephan Dirnhofer; Leticia Quintanilla-Martinez; Birgitta Sander; John K C Chan; Elias Campo; Steven H Swerdlow; German Ott
Journal:  Virchows Arch       Date:  2015-10-19       Impact factor: 4.064

3.  IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution.

Authors:  Mariette Odabashian; Emanuela Carlotti; Shamzah Araf; Jessica Okosun; Filomena Spada; John G Gribben; Francesco Forconi; Freda K Stevenson; Mariarita Calaminici; Sergey Krysov
Journal:  Blood       Date:  2020-03-12       Impact factor: 22.113

Review 4.  Altered N-Linked Glycosylation in Follicular Lymphoma and Chronic Lymphocytic Leukemia: Involvement in Pathogenesis and Potential Therapeutic Targeting.

Authors:  Nurit Hollander; Joseph Haimovich
Journal:  Front Immunol       Date:  2017-08-02       Impact factor: 7.561

5.  Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia.

Authors:  Perikles Kosmidis; Irina Bonzheim; Claudia Dufke; Sema Colak; Thomas Hentrich; Christopher Schroeder; Peter Bauer; Patrick Adam; Falko Fend
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

6.  In-Depth Mapping of the Urinary N-Glycoproteome: Distinct Signatures of ccRCC-related Progression.

Authors:  Lucia Santorelli; Giulia Capitoli; Clizia Chinello; Isabella Piga; Francesca Clerici; Vanna Denti; Andrew Smith; Angelica Grasso; Francesca Raimondo; Marco Grasso; Fulvio Magni
Journal:  Cancers (Basel)       Date:  2020-01-18       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.